Recent Developments and Limitations of Poloxamine-Coated Long-Circulating Particles in Experimental Drug Delivery

  • S. M. Moghimi
Part of the NATO ASI Series book series (NSSA, volume 300)


There has been growing interest in the engineering of colloidal carrier systems that upon intravenous administration avoid rapid recognition by scavenger cells of the reticuloendothelial system and adequately remain in the blood. There are several reasons as to why the search for such ‘phagocyte-resistant’ or long-circulating particles is so extensive. First, long-circulating drug carriers may act as a’ sustained release system’ in the blood and slowly discharge their entrapped materials for better treatment and diagnosis. Secondly, long-circulating drug carriers may passively accumulate in pathological sites with affected vasculature (e.g., selected tumours, rheumatoid arthritis, infections) and improve or enhance treatment or diagnosis in those areas (Bakker-Woudenberg et al., 1993; Wu et al., 1993; Huang et al., 1994; Yuan et al., 1994). Thirdly, grafting or covalent attachment of homing molecules such as antibodies, peptides that mimic ligands for αvβ3 and αvβ5 integrins, oligosaccharides that mimic ligands for P-selectin (e.g., synthetic sialyl-Lewis X and small heparin chains containing four or more monosaccharide residues), folate, etc. to long-circulating carries can dramatically improve the targeting precision to sites beyond the reticuloendothelial system (e.g., vascular and tumour endothelial cells, circulating blood cells, circulating toxic materials) (Mulligan et al., 1993; Nelson et al., 1993; Lee and Low, 1994; Bloemen et al., 1995; Gabizon, 1995; Moghimi, 1995a, c; Torchilin, 1995; Lee and Huang, 1996; Huang et al., 1997; Pasqualini et al., 1997).


Kupffer Cell Latex Bead Polystyrene Bead Polyoxyethylene Ether Sustained Release System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bakker-Woudenberg, I.A.J.M., Lokerse, A.F., Ten Kate, M., Mouton, J.W., Woodle, M.C., and Storm, G., 1993, Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae infected lung tissue, J. Infect Dis 168:164.PubMedCrossRefGoogle Scholar
  2. Bloemen, P.G.M., Henricks, P.A.J., van Bloois, L., van den Tweel, M.C., Bloem, A.C., Nijkamp, F.P., Crommelin, D.J., and Storm, G., 1995, Adhesion molecules: a new target for immuno liposomemediated drug delivery, FEBS Lett 357: 140.PubMedCrossRefGoogle Scholar
  3. Colbassani H.J., Barrow D.L., Sweeny, K.M., Bakay, R.A., Check, I.J., and Hunter, R.L., 1989, Modification of acute focal ischemia in rabbits by poloxamer 188, Stroke 20: 1241.PubMedCrossRefGoogle Scholar
  4. Gabizon, A.A., 1995, Liposome circulation time and tumor targeting: implications for cancer chemotherapy, Adv Drug Deliv Rev 16:285.CrossRefGoogle Scholar
  5. Geyer, R.P., 1967, Studies on the metabolism of intravenous fat emulsions, Fette Med 6:59.Google Scholar
  6. Gordon, S., Lawson, L., Rabinowitz, S., Crocker, P.R., Morris, L., and Perry, V.H., 1992, Antigen markers of macrophage differentiation in murine tissues, Curr Topic Microbiol Immunol 181: 1.CrossRefGoogle Scholar
  7. Griffin, F.M., Jr., and Mullinax, P.J., 1981, Augmentation of macrophage complement receptor function in vitro. II. C3b receptors that promote phagocytosis migrate within the plane of the macrophage plasma membrane, J Exp Med 154: 291.PubMedCrossRefGoogle Scholar
  8. Hart, P.D., and Payne, S.N., 1971, Effects of non-ionic surfactants that modify experimental tuberculosis on lipase activity of macrophages, Br J Pharmacol 43: 190.PubMedCrossRefGoogle Scholar
  9. Howerton, D.A., Hunter, R.L., Ziegler, H.K., and Check, I.J., 1990, Induction of macrophage Ia expression in vivo by a synthetic block copolymer, L81, J Immunol 144: 1578.PubMedGoogle Scholar
  10. Huang, X., Molema, G., King, S., Watkins, L., Edgington, T.S., and Thorpe, P.E., 1997, Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature, Science 275: 547.PubMedCrossRefGoogle Scholar
  11. Huang, S.K., Stauffer, P. R., Hong, K., Guo, J.W.H., Phillips, T.L., Huang, A., and Papahadjopoulos, D., 1994, Liposome hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin of sterically stabilized liposomes, Cancer Res 54: 2186.PubMedGoogle Scholar
  12. Hunter, R., Strickland, F., and Kézdy, F., 1981, The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance, J Immunol 127:1244.PubMedGoogle Scholar
  13. Ingram, D.A., Forman, M, and Murray, J.J., 1992, Phagocytic stimulation of human neutrophils by the detergent component of Fluosol, Am J Pathol 140: 1081.PubMedGoogle Scholar
  14. Jeppsson, R., and Rossner, S., 1975, The influence of emulsifying agents and of lipid soluble drugs on the fractional removal rate of lipid emulsions from the blood stream of rabbit, Acta Pharmacol Toxicol 37: 134.CrossRefGoogle Scholar
  15. Kolb-Bachofen, V., and Abel, F., 1991, Participation of D-galactose-specific receptors of liver macrophages in recognition of fibronectin-opsonized particles, Carbohydrate Res 213:201.CrossRefGoogle Scholar
  16. Lee, S.H., Crocker, P., and Gordon, S., 1986, Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood, J Exp Med 163:54.PubMedCrossRefGoogle Scholar
  17. Lee, R.J., and Huang, L., 1996, Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer, J Biol Chem 271:8481.PubMedCrossRefGoogle Scholar
  18. Lee, R.J., and Low, P.S., 1994, Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis, J Biol Chem 269:3198.PubMedGoogle Scholar
  19. Lee, J., Martic, P.A., and Tan, J.S., 1989, Protein adsorption on pluronic co-polymers coated polystyrene particles, J Colloid Interface Sci 131:252.CrossRefGoogle Scholar
  20. Lepay, D.A., Steinman, R.M., Nathan, C.F., Murray, H.W., and Cohen, Z.A., 1985, Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates, J Exp Med 161:1503.PubMedCrossRefGoogle Scholar
  21. Li, J.T., and Caldwell, K.D., 1994, Rapoport, N. Surface properties of pluronic-coated polymeric colloids, Langmuir 10:4475.CrossRefGoogle Scholar
  22. Mayer D.C., Strada S.J., Hoff, C, Hunter, R.L., and Artmann, M., 1994, Effects of poloxamer 188 in a rabbit model of hemorrhagic shock, Annal Clin Lab Sci 24: 302.Google Scholar
  23. Moghimi, S.M., 1995a, Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymers, Adv Drug Deliv Rev 16:183.CrossRefGoogle Scholar
  24. Moghimi, S.M., 1995b, Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents, Adv Drug Deliv Rev 17:103.CrossRefGoogle Scholar
  25. Moghimi, S.M., 1995c, Exploiting bone marrow microvascular structure for drug delivery and future therapies, Adv Drug Deliv Rev 17:61.CrossRefGoogle Scholar
  26. Moghimi, S.M., 1997, Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A reticuloendothelial blockade event or manipulation of nanosphere surface in vivo?, Biochim Biophys Acta 1336:1.PubMedCrossRefGoogle Scholar
  27. Moghimi, S.M., and Gray, T.A., 1997, A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats, Clin Science 93:371.Google Scholar
  28. Moghimi, S.M., Hawley, A.E., Christy, N.M., and Gray, T., 1994, Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes, FEBS Lett 344, 25.PubMedCrossRefGoogle Scholar
  29. Moghimi, S.M., Hedeman, H., Christy, N.M., Ilium, L., and Davis, S.S., 1993a, Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats, J Leukoc Biol 54:513.PubMedGoogle Scholar
  30. Moghimi, S.M., Hedeman, H., Ilium, L., and Davis, S.S. 1993b, Effect of splenic congestion associated with haemolytic anaemia on filtration of’ spleen-homing’ microspheres, Clin Science 84: 605.Google Scholar
  31. Moghimi, S.M., Hedeman, H., and Muir, I.S., 1993c, An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen, Biochim Biophys Acta 1157:233.PubMedCrossRefGoogle Scholar
  32. Moghimi, S.M., Muir, I.S., Ilium, L., Davis, S.S., and Kolb-Bachofen, V., 1993d, Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum, Biochim Biophys Acta 1179:157.PubMedCrossRefGoogle Scholar
  33. Moghimi, S.M., and Murray, J.C., 1996, Poloxamer-188 revisited: a potential valuable immune modulator?, J Natl Cancer Inst 88: 766.PubMedCrossRefGoogle Scholar
  34. Moghimi, S.M., and Patel, H.M., 1998, Serum-mediated recognition of liposomes by phagocytes of the reticuloendothelial system — The concept of tissue specificity, Adv Drug Deliv Rev (in press).Google Scholar
  35. Moghimi, S.M., Porter, C.J.H., Muir, I.S., Ilium, L., and Davis, S.S., 1991, Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating, Biochem Biophys Res Commun 177:861.PubMedCrossRefGoogle Scholar
  36. Moghimi, S.M., and Rajabi-Siahboomi, A.R., 1996, Advanced colloid based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues, Prog Biophys Mol Biol 65:221.PubMedCrossRefGoogle Scholar
  37. Mulligan, M.S., Paulson, J.C., Frees, S.D., Zheng, Z., Lowe, J.B., and Ward, P.A., 1993, Protective effects of oligosaccharides in P-selectin-dependent lung injury, Nature 364:149.PubMedCrossRefGoogle Scholar
  38. Naper, D.H., 1983, Polymeric Stabilization of Colloidal Dispersions, Academic Press, New York.Google Scholar
  39. Needham, D., McIntosh, T.J., and Lasic, D.D., 1992, Repulsive interactions and mechanical stability of polymer-grafted lipid membranes, Biochim Biophys Acta 1108:40.PubMedCrossRefGoogle Scholar
  40. Nelson, R.M., Cecconi, O., Roberts, W.G., Aruffo, A., Linhardt, R.J., and Bevilacqua, M.P., 1993, Heparin oligosaccharides bind L-and P-selectin and inhibit acute inflammation, Blood 82: 3253.PubMedGoogle Scholar
  41. Norman, M.E., Williams, P., and Ilium, L., 1992, Human serum albumin as a probe for protein adsorption (opsonisation) to block co-polymer coated microspheres, Biomaterials 13:841.PubMedCrossRefGoogle Scholar
  42. Norman, M.E., Williams, P., and Ilium, L., 1992, Influence of block copolymers on the adsorption of plasma proteins to microspheres, Biomaterials 14: 193.CrossRefGoogle Scholar
  43. Pasqualini, R., Koivunen, E., and Ruoslahti, E., 1997, αv Integrins as receptors for tumor targeting by circulating ligands, Nature Biotech 15:542.CrossRefGoogle Scholar
  44. Schmolka, I.R., 1977, A review of block polymer surfactants, J Am Chem Soc 54: 110.Google Scholar
  45. Scott, M.D., Murad, K.L., Koumpouras, F., Talbot, M., and Eaton, J.W., 1997, Chemical camouflage of antigenic determinants: Stealth erythrocytes, Proc Natl Acad Sci USA, 94:7566.PubMedCrossRefGoogle Scholar
  46. Silk, M., and Sigman, E., 1972, Effect of Pluronic-F68 on the development of tumor metastasis, Cancer 29:171.PubMedCrossRefGoogle Scholar
  47. Torchilin, V.P., 1995, Targeting of drugs and drug carriers within the cardiovascular system, Adv Drug Deliv Rev 17:75.CrossRefGoogle Scholar
  48. Torchilin, V.P., Omelyanenko, V.G., Papisov, I.M., Bogdanov, A.A., Jr, Trubetskoy, V.S., Herron, J.N., and Gentry, C.A., 1994, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposomes, Biochim Biophys Acta 1195:11.PubMedCrossRefGoogle Scholar
  49. Troster, S.D., Müller, U., and Kreuter, J., 1990, Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants, Int J. Pharm 61:85.CrossRefGoogle Scholar
  50. Vogel, S.N., and Rosenstreich, D.L., 1979, Defective Fc receptor-mediated phagocytosis in C3H / HeJ macrophages. I. Correction by lymphokine-induced stimulation, J Immunol 123: 2842.PubMedGoogle Scholar
  51. Watrous-Peltier, N., Uhl, J., Steel, V., Brophy, L., and Merisko-Liversidge, E., 1992, Direct suppression of phagocytosis by amphipathic polymeric surfactants, Pharm Res 9: 1177.PubMedCrossRefGoogle Scholar
  52. Woodcock, D. M., Linsenmeyer, M. E., Chojnowski, G., Kriegler, A.B., Nink, V., Webster, L.K., and Sawyer, W.H., 1992, Reversal of multidrug resistance by surfactants, Br J Cancer 66: 62.PubMedCrossRefGoogle Scholar
  53. Wu, N. Z., Da, D., Rudoll, T.L., Needham, D., Whorton, A.R., and Dewhirst, M.W., 1993, Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue, Cancer Res 53:3765.PubMedGoogle Scholar
  54. Yuan, F., Leunig, M., Huang, S.K., Berk, D.A., Papahadjopoulos, D., and Jain, R., 1994, Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft, Cancer Res 54: 3352.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • S. M. Moghimi
    • 1
  1. 1.Department of PharmacyUniversity of BrightonBrightonUK

Personalised recommendations